Differential activation of Gq/1 and Gi3 proteins at 5-hydroxytryptamine2C receptors revealed by antibody capture assays:: Influence of receptor reserve and relationship to agonist-directed trafficking

被引:96
作者
Cussac, D [1 ]
Newman-Tancredi, A [1 ]
Duqueyroix, D [1 ]
Pasteau, V [1 ]
Millan, MJ [1 ]
机构
[1] Inst Rech Servier, Dept Psychopharmacol, F-78290 Paris, France
关键词
D O I
10.1124/mol.62.3.578
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
As determined by a guanosine 5'-O-(3-[S-35] thio) triphosphate ([S-35] GTPgammaS) binding assay, which does not distinguish G protein subtypes, 5-hydroxytryptamine (5-HT) and 2(S) 1-( 6-chloro-5-fluoro-1H-indol-1-yl)-2-propanamine fumarate (Ro600175) behaved as full agonists at human 5-HT2C (h5-HT2C) receptors (VSV isoform) stably expressed in Chinese hamster ovary (CHO) cells, whereas 1-2,5-dimethoxy-4-iodophenyl- 2-aminopropane (DOI), d-lysergic acid diethylamide (LSD), and lisuride exhibited partial agonist properties. After treatment with pertussis toxin to uncouple 5-HT2C receptors from Gi/Go but not Gq/11, DOI and LSD were as efficacious as 5-HT and Ro600175 in stimulating [S-35] GTPgammaS binding, whereas lisuride still exhibited low efficacy (40%). Correspondingly, in a scintillation proximity assay employing specific antibodies against Gq/11, 5-HT, Ro600175, DOI, and LSD behaved as high-efficacy agonists, whereas lisuride showed efficacy of 36%. In contrast, when employing a specific antibody recognizing Gi(3), DOI and LSD were less efficacious (80 and 30%, respectively) than 5-HT and Ro600175, and lisuride was inactive. Agonist actions were specifically mediated by h5-HT2C receptors inasmuch as the selective 5-HT2C antagonist SB242,084 blocked [S-35] GTPgammaS binding at both Gq/11 and Gi(3). Agonist potency for stimulation of Gi(3) was similar to6- to 8-fold less than for Gq/11, indicating that the latter was preferentially engaged by h5-HT2C receptors. Inactivation of h5-HT2C receptors with the alkylating agent N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline did not modify the efficacy of 5-HT, Ro600175, and DOI at Gq/11, whereas their efficacies were substantially reduced at Gi(3), indicating a greater receptor reserve for the former. Finally, the preferential activation of Gq/11 versus Gi(3) by DOI, LSD, and lisuride was diminished in the presence of lower receptor number. In conclusion, h5-HT2C receptors couple to both Gq/11 and Gi(3) in CHO cells, and efficacy for G protein subtype activation is both ligand- and receptor reserve-dependent.
引用
收藏
页码:578 / 589
页数:12
相关论文
共 54 条
[1]   Gq/11 and Gi/o activation profiles in CHO cells expressing human muscarinic acetylcholine receptors:: dependence on agonist as well as receptor-subtype [J].
Akam, EC ;
Challiss, RAJ ;
Nahorski, SR .
BRITISH JOURNAL OF PHARMACOLOGY, 2001, 132 (04) :950-958
[2]   Agonist-induced GTPγ35S binding mediated by human 5-HT2C receptors expressed in human embryonic kidney 293 cells [J].
Alberts, GL ;
Pregenzer, JF ;
Im, WB ;
Zaworski, PG ;
Gill, GS .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 383 (03) :311-319
[3]   Agonist-directed signaling of serotonin 5-HT2C receptors:: Differences between serotonin and lysergic acid diethylamide (LSD) [J].
Backstrom, JR ;
Chang, MS ;
Chu, H ;
Niswender, CM ;
Sanders-Bush, E .
NEUROPSYCHOPHARMACOLOGY, 1999, 21 (02) :S77-S81
[4]  
Berg KA, 1999, MOL PHARMACOL, V55, P863
[5]   RNA-editing of the 5-HT2C receptor alters agonist-receptor-effector coupling specificity [J].
Berg, KA ;
Cropper, JD ;
Niswender, CM ;
Sanders-Bush, E ;
Emeson, RB ;
Clarke, WP .
BRITISH JOURNAL OF PHARMACOLOGY, 2001, 134 (02) :386-392
[6]   Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: Evidence for agonist-directed trafficking of receptor stimulus [J].
Berg, KA ;
Maayani, S ;
Goldfarb, J ;
Scaramellini, C ;
Leff, P ;
Clarke, WP .
MOLECULAR PHARMACOLOGY, 1998, 54 (01) :94-104
[7]   Molecular tinkering of G protein-coupled receptors: an evolutionary success [J].
Bockaert, J ;
Pin, JP .
EMBO JOURNAL, 1999, 18 (07) :1723-1729
[8]  
Bonhaus DW, 1998, J PHARMACOL EXP THER, V287, P884
[9]  
Brink CB, 2000, J PHARMACOL EXP THER, V294, P539
[10]   Regulation of serotonin-2C receptor G-protein coupling by RNA editing [J].
Burns, CM ;
Chu, H ;
Rueter, SM ;
Hutchinson, LK ;
Canton, H ;
SandersBush, E ;
Emeson, RB .
NATURE, 1997, 387 (6630) :303-308